Adaphostine, a tyrphostin kinase inhibitor is able to induce up-regulation of ROS and cause DNA damage-induced apoptosis in BCR-ABL–expressing CML [158]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.